Search Results

UNBS5162 50mg 50mg  | Purity Not Available

Adooq Bioscience

UNBS5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers; the mean antiproliferative activity IC50 value is 17.9 uM for 9 cancer cell lines; hydrolysis product of UNBS3157.

More Information Supplier Page

UNBS5162 25mg 25mg  | Purity Not Available

Adooq Bioscience

UNBS5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers; the mean antiproliferative activity IC50 value is 17.9 uM for 9 cancer cell lines; hydrolysis product of UNBS3157.

More Information Supplier Page

UNBS5162 10mg 10mg  | Purity Not Available

Adooq Bioscience

UNBS5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers; the mean antiproliferative activity IC50 value is 17.9 uM for 9 cancer cell lines; hydrolysis product of UNBS3157.

More Information Supplier Page

SB271046 HCl 50mg 50mg  | Purity Not Available

Adooq Bioscience

SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.

More Information Supplier Page

SB271046 HCl 25mg 25mg  | Purity Not Available

Adooq Bioscience

SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.

More Information Supplier Page

Vigabatrin 25mg 25mg  | Purity Not Available

Adooq Bioscience

Vigabatrin is an antiepileptic drug that inhibits the breakdown of gamma-aminobutyric acid (GABA) by acting as a suicide inhibitor of GABA transaminase (GABA-T).

More Information Supplier Page

Vigabatrin 50mg 50mg  | Purity Not Available

Adooq Bioscience

Vigabatrin is an antiepileptic drug that inhibits the breakdown of gamma-aminobutyric acid (GABA) by acting as a suicide inhibitor of GABA transaminase (GABA-T).

More Information Supplier Page